drugset / Trial / NCT00359476
A Study of Vinflunine in Patients With Gastric Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to learn if vinflunine can shrink or slow the growth of cancer in patients with advanced or metastatic stomach cancer who have progressed on a prior treatment with a fluoropyrimidine or taxane-containing chemotherapy regimen. The safety of this treatment will also be studied.
Timeline
- Start
- 2007-03
- Primary completion
- 2007-10
- Completion
- 2007-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vinflunine | Small molecule | 280 mg/m2 | Intravenous |
| Subject | Vinflunine | Small molecule | 320 mg/m2 | Intravenous |